跳至主要内容
临床试验/NCT04577274
NCT04577274已完成不适用

Impact of High Protein and Low Carbohydrate Smoothie Drinks Versus Diabetes-specific Nutritional Formulas on Postprandial Glucose Homeostasis in Type-2 Diabetes Mellitus

Mahidol University1 个研究点 分布在 1 个国家目标入组 43 人开始时间: 2020年11月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
43
试验地点
1
主要终点
Change from baseline Glycemia at 240 minutes

研究概览

简要总结

We compared between a regular high protein or a high protein and low carbohydrate smoothie drinks with conventional diabetic enteral drinks (Glucerna) on glucose homeostasis, insulin and lipid metabolism in type 2 diabetic and obese individuals.

详细描述

We aimed to determine the effect of high protein and low carbohydrate smoothie drinks on glucose homeostasis, insulin and lipid metabolism in type 2 diabetic and obese individuals. We compared between a regular high protein or a high protein and low carbohydrate smoothie drinks with conventional diabetic enteral drinks (Glucerna). A crossover design study was done in 60 diabetic participants. Participants consumed 300 kilocalories of each drink at a time with one week wash out period between drinks and glucose response curves at baseline, 30, 60, 90, 120, 180 and 240 minutes were monitored and compared. The products were formulated to supply 1 kilocalorie/milliliter (kcal/ml). Dietary compositions in regular formulas (smoothie, SM) were 30-40% carbohydrate, 20-30% protein and 30-50% fat. While in smoothie with low carbohydrate formulas (SMLS), they were 25-35% carbohydrate, 25-30% protein and 35-55% fat vs. a control formula (Glucerna).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •people with type 2 diabetes mellitus or use blood glucose-lowering drugs more than 3 months
  • •BMI > 25 kg/m^2
  • •HbA1c 6.5 - 8.5
  • •use stable level of blood glucose-lowering drugs and blood lipid-lowering drugs more than 3 months

排除标准

  • •pregnancy or breastfeeding
  • •people with chronic diseases or tube feeding or dysphagia i.e. pneumonia
  • •people with insulin injection or use GLP-1 analogues drugs or DPP-4 inhibitors drugs
  • •people with history of bariatric surgery, gastroparesis, malabsorption
  • •people with history of diseases that affect blood glucose/lipid control i.e. hyperthyroidism, endocrinology and kidney disorders
  • •use long-term immunosuppressants
  • •cancer patient

研究组 & 干预措施

smoothie with regular formulas (SM)

Experimental

Participants were given 300 kcal smoothie with regular formulas within 3-5 minutes and blood collection after drinking at 30, 60, 90, 120, 180 and 240 minutes.

干预措施: smoothie with regular formulas (SM) (Dietary Supplement)

smoothie with low carbohydrate formulas (SMLS)

Experimental

Participants were given 300 kcal smoothie with low carbohydrate formulas within 3-5 minutes and blood collection after drinking at 30, 60, 90, 120, 180 and 240 minutes.

干预措施: smoothie with low carbohydrate formulas (SMLS) (Dietary Supplement)

conventional diabetic enteral drinks (Glucerna)

Active Comparator

Participants were given 300 kcal Glucerna within 3-5 minutes and blood collection after drinking at 30, 60, 90, 120, 180 and 240 minutes.

干预措施: conventional diabetic enteral drinks (Glucerna) (Dietary Supplement)

结局指标

主要结局

Change from baseline Glycemia at 240 minutes

时间窗: Minutes after intake of each smoothie formula: 0, 30, 60, 90, 120, 180, 240

glucose (mg/dl)

Change from baseline Insulin at 240 minutes

时间窗: Minutes after intake of each smoothie formula: 0, 30, 60, 90, 120, 180, 240

insulin (μU/ml)

次要结局

  • Age(Baseline)
  • Weight(Baseline)
  • Height(Baseline)
  • Body Mass Index(Baseline)
  • Waist circumference(Baseline)
  • Blood pressure(Baseline)
  • Complete Blood Count (CBC)(Baseline)
  • glycosylated hemoglobin (HbA1C)(Baseline)
  • liver aminotransferaces activity - Serum glutamate oxaloacetate transaminase (SGOT)(Baseline)
  • liver aminotransferaces activity - Serum glutamate pyruvate transaminase (SGPT)(Baseline)
  • lipid profiles concentration analysis(Baseline)
  • Creatinine concentration analysis(Baseline)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验